Sep 29

PQA 06 - PQA 06: Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement

3344 - A Phase I/II Dose-Escalation Study Evaluating the Safety of 21 Gy, 23 Gy, and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy: An Interim Report

02:15pm - 03:30pm ET

Presenter(s)

Michael Padgett, MD - Washington University in St. Louis, St. Louis, MO